Lecture 24 Transplantation Immunology Flashcards

1
Q

autograft

A

transplant from one anatomical location to another on the same person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

isograft

A

transplant from one individual who is syngeneic to the donor (identical twin) HISTOCOMPATIBLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

allograft

A

transplant from one individual to a genetically dissimilar individual HISTOINCOMPATIBLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

alloantigens

A

antigens that differ between members of the same species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

xenograft

A

graft between donor and recipient from different species; HISTOINCOMPATIBLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Bone Marrow and HSC transplantation

A

allogeneic and autologous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which type of transplants would you expect to see rejection?

A

allograft and xenograft because they are HISTOINCOMPATIBLE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Allogeneic bone marrow transplant runs a risk for

A

graft vs host disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Colony stimulating factors include

A

granulocyte-monocyte-CSF or IL-13

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Autologous bone marrow transplant

A

HSC or bone marrow from same individual following CD34, cryopreservation, ablative therapy followed by reintroduction of frozen HSC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

First-set rejection

A

first graft from a histoincompatible donor leads to rejection in 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Second-set rejection (immunological memory)

A

second graft from the same donor will be completely rejected within a week

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which type of individuals would not reject an allograft

A

athymic - T cell plays a large role in rejection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Hyperacute rejection

A

within hours, pre-formed antibodies to incompatible MHC or blood group antigens and activation of complement causes a reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Hyperacute rejection is mediated by

A

present antibodies binding to tissue inducing complement and recruitment of phagocytic cells, platelet activation -> thrombosis -> hemorrhage -> necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pre-formed antibodies may be present as a result of

A

ABO incompatibility, previous incompatible transfusion, pre void blood transfusion from related donor, pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Manifestations of hyperacute rejection

A

fever, leukocytosis, loss of function of organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Therapy for hyperacute rejection

A

NONE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acute rejection

A

within days, non-sensitized patients’ T cell-mediated immunity recognizes mismatch of HLA types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acute rejection is complete by

A

14 days, may be shorter in sensitized patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Acute rejection occurs when

A

there is a mismatch or incomplete match in HLA types

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Histological definition of acute rejection

A

infiltration of lymphocytes and monocytic macrophages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

destruction of cells in acute rejection occurs by

A

cytotoxic T cells, phagocytosis and presentation of transplant antigen to help T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Therapy for acute rejection

A

immunsuppressive therapy (antibodies against T lymphocytes, corticosteroids, or other drugs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Histological definition of chronic rejection
lymphoid proliferation and formation of lymphoid follicles, fibrotic changes
26
Chronic rejection
over months or years, CD4+ cell activation along with macrophage activation, cytotoxic T cell activation, antibody produced against allograft antigens, classical complement, and ADCC cause loss of function of organ
27
Therapy for chronic rejection
none, damage has been done
28
Graft vs host disease
transplantation of donor lymphocytes or precursors genetically dissimilar can ATTACK RECIPIENT's tissue
29
To avoid Graft vs host disease
immunocompetent lymphocytes from donor and recipient must be immune compromised
30
Manifestations of Graft vs host disease
rash, hepato-slpenomagaly, lymphadenopathy, diarrhea, anemia, weight loss, wasting
31
Graft-versus-leukemia effect
donor T cells recognize minor histocompatibility or tumor-specific antigens and attack and kill leukemic cells, reducing the reoccurrence
32
Major Histocompatibility Complex (MHC)
primary immunological importance in graft acceptance or rejection
33
transplantation agents
MHC
34
HLA
products of the MHC gene complex
35
MHC class I is composed of
several closely linked genes or loci known as A, B, C
36
MHC class II is composed of
several closely linked genes or loci known as DP, DQ, and DR
37
HLA class I are expessed on
All nucleated cells
38
HLA class II are expressed on
a subset of hematopoietic cells (dendritic cells) and thymocytes
39
HLA class II can be induced by what cytokine
INF-gamma
40
Haplotype of MHC
combination of 6 alleles (one for each A, B, C, DP, DQ, and DR
41
Genotype of MHC
2 haplotypes, 1 from each parent = 12 alleles expressed
42
Use of HLA alleles for
MHC genetic polymorphisms is the basics for forensics, paternity testing, DNA ancestry, tissue typing
43
MHC is inherited as
a block of genes from each parent, because they are so closely linked
44
The most potent transplant antigen is
MHC Class II HLA-DR
45
The key initiating event in allograft rejection is
direct activation of the recipient's CD4+ T cells by NONSELF HLA Class II molecules from donor
46
Direct recognition
recognition of nonself HLA molecules does not require processed foreign peptides, instead CD4 recognized non-self HLA alone
47
In direct recognition, because CD4 TCR does not need HLA + peptide for recognition, the body mounts a
much broader immune response (5% of all T cells respond)
48
indirect recognition
receipient's APC processes donor antigens and presents them to T cells
49
Which locus is associated with the longest graph survival
HLA-DR
50
Activation of CD4+ cells via
recognition of foreign HLA class II (with or without peptide) occurs
51
Activation of CD8+ T cells via
direct activation by nonself HLA class I UT require the assistance of CD4+ T cells via IL-2 production
52
Important cytokines in allograft rejection are predominantly
Th1, hence graft rejection reflects a type 1 immune reponse
53
IFN-gamma role in allograft rejection
accumulation and activation of macrophages and increased HLA Class II expression, cytolytic response
54
IFN-gamma and IFN-alpha/beta and TNF-alpha and beta role in allograft rejection
increase HLA class I expression and result in cytolysis of transplanted cells
55
TNF-beta role in allograft rejection
cytotoxic to graft cells
56
Tissues that are highly dependent on HLA matching for survival
bone marrow and kidney
57
Tissues that are moderately dependent on HLA matching for survival
heart and liver
58
Tissues that are not dependent on HLA matching for survival
cornea
59
What is the reason for graft rejection when 2 individuals are HLA-matched
Minor histocompatibility antigens
60
reaction due to minor histocompatibility antigens is
not as rapid, but patients must still be under immunosuppressive therapy to prevent graft rejection
61
Testing for histocompatibility
blood typing and cross-match (ABO mismatch = hyperacute rejection), genotyping HLA by PCR
62
Genotpying HLA alleles by PCR
HLA sequence-based typing (HLA-SBT), PCR, DNA sequencing, comparison to known allele sequences
63
Prevention of allograft rejection
all medications are not antigen-specific, but rather induce generalized immune suppression
64
Tissue typing (lymphocytotoxicity)
antibodies against known HLA sequence-marker is added to cells, cells stained indicate +HLA marker
65
Mixed Leukocyte Reaction (1 way)
known LIVING donor available, highly sensitivite for major and minor HC, mix recipient and donor cells together (inactivate 1) if T cell reconizes other as foreign then cells divide and incorporate thymidine in DNA. If not foreign, no proliferation and no uptake
66
Corticosteroids
inhibit T cell cytokine production and HLA expression (-ones)
67
Antimetabolites
azathioprine and mercaptopurine - inhiibit lymphocyte proliferation - purine agonist; cyclophosphamide and chlorambucil - DNA alkylating agents; methotrexate - folic acid antagonist
68
azathioprine
inhibit lymphocyte proliferation - purine agonist
69
mercaptopurine
inhibit lymphocyte proliferation - purine agonist
70
cyclophosphamide
DNA alkylating agents
71
chlorambucil
DNA alkylating agents
72
methotrexate
folic acid antagonist
73
Blocking agents
antibodies against CD-3, IL-2 receptor, B7 ligands
74
Antibody against CD-3
blocks T cell activation
75
Antibody against IL-2R
receptor on T cells
76
Antibody against B7 ligands
blocks effects of co-stimulating molecules
77
Cyclosporine
inhibits T cell cytokine production by interfering with gene transcription
78
FK506 and rapamycin
similar to cyclosporine - inhibits T cell cytokine production by interfering with gene transcription